Mutations in the LRRK2 gene can lead to abnormal kinase activity, which in turn disrupts various cellular processes. For instance, it may affect dopaminergic neurons in the substantia nigra, a brain region crucial for motor control. The resultant neuronal dysfunction and death contribute to the motor symptoms characteristic of Parkinson's disease, such as tremors, rigidity, and bradykinesia.
